Clayton Eye Clinical Research | Morrow, GA

Research site

(Unclaimed)

Location

1000 Corporate Center Drive, Suite 120, Morrow, Georgia, United States of America

Site insights

Top conditions

Top treatments

DE-117

Timolol Maleate

AGN-190584

DE-126

Bimatoprost

K-321

Phentolamine Mesylate

STN1013600

DFL24498

Perfluorohexyloctane

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 24 total trials

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

This is a multicenter, randomized, double-masked, placebo-controlled pilot study conducted in the United States (US) in subjects with age-related cat...

Invitation-only

Age Related Cataracts

Drug: Control

Drug: 0.4% ZOC2017217

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Comb...

Enrolling

Dry Eye Disease

Drug: Vehicle

Drug: Lifitegrast/Perfluorohexyloctane Fixed Dose Combination

An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

This is a phase 3, multicenter, randomized, double-masked, parallel-group, vehicle-controlled study to evaluate the safety and efficacy of DFL24498 c...

Enrolling

Atopic Keratoconjunctivitis

Drug: DFL24498

Drug: dexamethasone sodium phosphate (DSP) ophthalmic solution

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonst...

Enrolling

Ocular Hypertension

Glaucoma, Open-Angle

Drug: Test - Bimatoprost 0.01% Ophthalmic Solution

Drug: Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)